The company reaffirmed its fiscal-year revenue guidance earlier this month, calling for sales to nearly triple to $145 million to $150 million, but the stock is likely to struggle if the vaping backlash continues to constrain its ability to raise cash. With many medical and recreational marijuana users on edge following the recent vape-related health scares caused by counterfeit and/or bootlegged products, more and more cannabis companies are joining. MAKE NO MISTAKE THE MYSTERY ILLNESS IS THE INDUSTRY PLAN TO ATTACK THE BLACK MARKET
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.